Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
SurModics (SRDX) Misses Q2 EPS by 2c; Narrows Outlook
April 27, 2017 7:39 AM EDTSurModics (NASDAQ: SRDX) reported Q2 EPS of $0.05, $0.02 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $17.5 million versus the consensus estimate of $16.23 million.
Total Revenue of $17.5 Million, up 5% year over year; Medical Device revenueincreases 10%EPS of $0.04, Non-GAAP EPS of $0.05Narrows financial outlook for... More